CDK4/6 inhibition versus mTOR blockade as second-line strategy in postmenopausal patients with hormone receptor-positive advanced breast cancer: A network meta-analysis.

Name: CDK4/6 inhibition versus mTOR blockade as second-line strategy in postmenopausal patients with hormone receptor-positive advanced breast cancer: A network meta-analysis.
Author: Huang, Hong-Wei

CDK4/6 inhibition versus mTOR blockade as second-line strategy in postmenopausal patients with hormone receptor-positive advanced breast cancer: A network meta-analysis. — المؤلف: Huang, Hong-Wei — Medicine 20190128

المؤلف: Huang, Hong-Wei
النشر: Medicine 20190128
الوصف: e13909 p.
الموضوعات: Aminopyridines؛ Androstadienes؛ Antineoplastic Agents؛ Antineoplastic Combined Chemotherapy Protocols؛ Benzimidazoles؛ Breast Neoplasms؛ ErbB Receptors؛ Everolimus